EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
4.3.2.2 | CuSO4 | complete inhibition at 0.05 mM | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
4.3.2.2 | 0.0091 | - |
succinyladenosine monophosphate | wild-type enzyme, pH 8.1, 37°C | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.3.2.2 | 1-(5-phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole | Homo sapiens | - |
5'-phosphoribosyl-5-amino-4-imidazolecarboxamide + fumarate | - |
? | |
4.3.2.2 | succinyladenosine monophosphate | Homo sapiens | - |
AMP + fumarate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.3.2.2 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
4.3.2.2 | erythrocyte | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.3.2.2 | 1-(5-phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole | - |
Homo sapiens | 5'-phosphoribosyl-5-amino-4-imidazolecarboxamide + fumarate | - |
? | |
4.3.2.2 | additional information | development of a rapid and simple HPLC-based assay method to quantitatively measure ADSL activity with succinyladenosine monophosphate in erythrocytes using isocratic ionpairing reversed-phase HPLC with UV-detection, overview | Homo sapiens | ? | - |
? | |
4.3.2.2 | succinyladenosine monophosphate | - |
Homo sapiens | AMP + fumarate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
4.3.2.2 | ADSL | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
4.3.2.2 | malfunction | ADSL enzyme deficiency is a disorder of purine metabolism with a broad clinical spectrum. The enzyme deficit causes a highly variable clinical presentation varying from a relatively mild presentation with slight motor retardation and severe muscle hypotonia to severe neonatal onset convulsions accompanied by severe mental retardation | Homo sapiens |
4.3.2.2 | metabolism | the enzyme is a bifunctional protein that is involved in both purine de novo synthesis and purine interconversion. It catalyzes the formation of phosphoribosylaminoimidazole carboxamide and succinate from phosphoribosylsuccinyl-aminoimidazole carboxamide in the biosynthesis of IMP from phosphoribosylpyrophosphate. Alternatively, the enzyme catalyzes the synthesis of AMP and succinate from succinyl-AMP in the interconversion of IMP into AMP | Homo sapiens |